2-Carboxy-1-[5-(2-carboxy-1-pyrrolidinyl)-2-hydroxy-2,4-pentadienylidene]pyrrolidinium

Metabolite details

Identifier

DJTFHMOANYEGKP-UHFFFAOYSA-N

InChI Key

DJTFHMOANYEGKP-UHFFFAOYSA-N

IUPAC name

1-[(2Z,4E)-5-(2-carboxypyrrolidin-1-yl)-2-hydroxypenta-2,4-dienylidene]pyrrolidin-1-ium-2-carboxylate

Preferred name

2-Carboxy-1-[5-(2-carboxy-1-pyrrolidinyl)-2-hydroxy-2,4-pentadienylidene]pyrrolidinium

INN name

—

Synonym

—

ChEBI

CHEBI:174204

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Metabolic Dynamics of In Vitro CD8+ T Cell Activation.
• Diallyl disulfide (DADS) ameliorates intestinal Candida albicans infection by modulating the gut microbiota and metabolites and providing intestinal protection in mice
• Intergenerational Association of Gut Microbiota and Metabolism between Perinatal Folic Acid Metabolism and Neural Tube Defects (Feces metabolomics)
• Interaction between Cervical Microbiota and Host Gene Regulation in Caesarean Section Scar Diverticulum
• Mechanism of interventional effect and targets of Zhuyu Pill in regulating and suppressing colitis and cholestasis
• Alterations in the gut microbiota and metabolomics of seafarers after a six-month sea voyage

Observed in differential profiles

• G3_Experimental_Sample_0h_vs_G11_Experimental_Sample_96h
• G1_PBS_vs_G2_DSS
• Normal_vs_Neural_Tube_Defect
• Control_vs_CSD
• Control_vs_ZYP_High_Dose
• Control_0d_vs_Treatment_180d